Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Viamet Pharmaceuticals discloses new cytochrome P450 inhibitors

March 26, 2013

Photochemical internalization of bleomycin using TPCS2a

March 26, 2013

Ohr Pharmaceutical reports results from phase II trial of OHR/AVR-118 in cancer cachexia

March 26, 2013

EMA committee recommends approval of ponatinib for two cancer indications

March 25, 2013

Cerulean's phase IIb study of CRLX-101 in NSCLC does not meet endpoint

March 25, 2013

Updated results from ALSYMPCA trial show survival benefit

March 25, 2013

Blueprint Medicines enters oncology collaboration

March 25, 2013

Cancer research institutions collaborate with Janssen to discover multiple myeloma drug

March 25, 2013

Elafin granted second FDA orphan drug designation

March 22, 2013

New protein kinase inhibitors divulged by New Hope R&D Bioscience

March 22, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...